Şunu aradınız:: carboplatino (İtalyanca - İngilizce)

carboplatino
cbdca

carboplatino/ paclitaxel
carboplatin/ paclitaxel

+ carboplatino (n=521)
+ carboplatin (n=521)

erlotinib e carboplatino/paclitaxel
erlotinib and carboplatin/paclitaxel

dose di carboplatino (auc mg•min/ml)1
dose of carboplatin (auc mg•min/ml)1

in associazione a chemioterapia adiuvante con docetaxel e carboplatino.
in combination with adjuvant chemotherapy consisting of docetaxel and carboplatin.

a i valori presentati sono per iressa verso carboplatino/paclitaxel.
trial outcome index results were supportive of fact-l and lcs results a values presented are for iressa versus carboplatin/paclitaxel.

non vi sono state interazioni farmacocinetiche clinicamente rilevanti fra abraxane e carboplatino.
there were no clinically relevant pharmacokinetic interactions between abraxane and carboplatin.

tabella 3 risultati di efficacia di gefitinib verso carboplatino/paclitaxel dello studio ipass
table 3 efficacy outcomes for gefitinib versus carboplatin/paclitaxel from the ipass study

tabella 9: reazioni avverse segnalate con abraxane in associazione con carboplatino (n = 514)
table 9: adverse reactions reported with abraxane in combination with carboplatin (n = 514)

fec: 5-fluorouracile, epirubicina, ciclofosfamide; tch: docetaxel, carboplatino e trastuzumab, cmh: cochran– mantel–haenszel
fec: 5-fluorouracil, epirubicin, cyclophosphamide; tch: docetaxel, carboplatin and trastuzumab, cmh: cochran–mantel–haenszel